Ganciclovir is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of CMV retinitis (IV) in immunocompromised pts.
- Prophylaxis and prevention of CMV disease recurrence in pts with AIDS and solid organ transplant recipients (use for primary prophylaxis in HIV is FDA approved but not currently recommended; valganciclovir preferred).
- Herpes keratitis (ophthalmic gel)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Castleman’s disease (limited data)
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: May 29, 2016
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ganciclovir
ID - 540238
A1 - Dzintars,Kathryn,Pharm.D. BCPS
AU - Hsu,Alice,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2016/05/29/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540238/all/Ganciclovir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -